Pagano Federica, Conti Maria Giulia, Boscarino Giovanni, Pannucci Chiara, Dito Lucia, Regoli Daniela, Di Chiara Maria, Battaglia Giuseppe, Prota Rita, Cinicola Bianca, Zicari Anna Maria, Aloi Marina, Oliva Salvatore, Terrin Gianluca
Department of Maternal and Child Health, Policlinico Umberto I Hospital, Sapienza University of Rome, 00161 Rome, Italy.
Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Children (Basel). 2021 Sep 24;8(10):843. doi: 10.3390/children8100843.
(1) Background: Preterm birth exposes the infant to the known risk factors for atopic diseases. We aimed to study the neonatal risk factors and to describe the clinical manifestations of atopy, including the march of symptoms, in a cohort of preschool children born preterm. (2) Methods: We enrolled neonates with gestational age < 32 weeks or birth weight < 1500 g. We classified patients in cases and controls according to the presence of at least one atopic manifestation. (3) Results: We observed 72 cases and 93 controls. Multivariate models showed that the administration of more than one cycle of antibiotics (B 0.902, = 0.026) and gestational diabetes (B 1.207, = 0.035) influence the risk of atopy in babies born preterm. In addition, risk of atopic dermatitis was influenced by gestational age < 29 weeks (B -1.710, = 0.025) and gestational diabetes (B 1.275, = 0.027). The risk of wheeze was associated with familiarity for asthma (B 1.392, = 0.022) and the administration of more than one cycle of antibiotics (B 0.969, = 0.025). We observed a significant reduction in the rate of atopic manifestation after 2 years of life (33.9% vs. 23.8%, < 0.05). (4) Conclusions: Modifiable (gestational diabetes, antibiotics use) and unmodifiable (familiarity for asthma) conditions influence the risk of atopy in babies born preterm. Extreme prematurity reduces the risk of atopic dermatitis. Preterm babies showed a peculiar atopic march.
(1) 背景:早产使婴儿面临患特应性疾病的已知风险因素。我们旨在研究早产学龄前儿童队列中的新生儿风险因素,并描述特应性的临床表现,包括症状发展过程。(2) 方法:我们纳入了孕周<32周或出生体重<1500克的新生儿。根据是否存在至少一种特应性表现将患者分为病例组和对照组。(3) 结果:我们观察到72例病例和93例对照。多变量模型显示,使用超过一个周期的抗生素(B 0.902,P = 0.026)和妊娠期糖尿病(B 1.207,P = 0.035)会影响早产婴儿患特应性疾病的风险。此外,特应性皮炎的风险受孕周<29周(B -1.710,P = 0.025)和妊娠期糖尿病(B 1.275,P = 0.027)影响。喘息风险与哮喘家族史(B 1.392,P = 0.022)和使用超过一个周期的抗生素(B 0.969,P = 0.025)有关。我们观察到2岁后特应性表现的发生率显著降低(33.9%对23.8%,P<0.05)。(4) 结论:可改变的(妊娠期糖尿病、抗生素使用)和不可改变的(哮喘家族史)情况会影响早产婴儿患特应性疾病的风险。极早早产会降低患特应性皮炎的风险。早产婴儿表现出特殊的特应性发展过程。